Co-processed tablet excipient composition, its preparation and use: US10071059 B2: patent spotlight

Pharm Pat Anal. 2023 Jan;12(1):19-25. doi: 10.4155/ppa-2022-0036. Epub 2022 Nov 16.

Abstract

Co-processing involves the incorporation of one excipients into the particle structure of other excipients to overcome the deficiencies of each excipients. The current patent describes the co-processing of microcrystalline cellulose and mannitol via fluid bed agglomeration with an aim to limit the use of lubricant in tablet composition. The co-processed excipients blend was compared with the physical blend of excipients and characterized for scanning electron microscopy, disintegration and hardness. The average particle size of co-processed excipients was less than 0.55 mm, characterized by large individual lactose-coated particles whereas, the physical blend particles are uncoated and irregular in shape. Tablets made from both physical blend and co-processed excipients were compared. As per the hardness and disintegration studies, with increase in mixing time of excipients both hardness and disintegration time decreases.

Keywords: co-processing; fluid bed agglomerator; lubricant; microcrystalline cellulose; sugar alcohol; tablet.

MeSH terms

  • Drug Compounding
  • Excipients* / chemistry
  • Hardness
  • Lactose* / chemistry
  • Tablets / chemistry

Substances

  • Excipients
  • Tablets
  • Lactose